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Background: The Psoriasis and Well-being (PsoWell)™ training programme incorporating Motivational 
Interviewing improves clinicians’ knowledge and skills to manage complex psoriasis including 
behaviour change. Objectives: To deliver the PsoWell™ training programme to dermatology specialists 
and evaluate the acceptability and feasibility of implementing the PsoWell™ model across 
dermatology services. Methods: Framework Analysis of 19 qualitative semi-structured interviews 
following delivery of nine, one-day PsoWell™ training days involving 119 participants.  Results: Two 
themes: Perceptions and Priorities and Awareness, which sub-divided into: Awareness Not 
Competence and Increasing Awareness. Conclusions: The PsoWell™ model is acceptable and feasible 
to implement across dermatology settings. Participants were more skilled and motivated to address 
psychological issues including behaviour change but wanted further training to ensure competency. 
They claimed scepticism among some colleagues regarding whole-patient management might prevent 
uptake. Data showing impact on health outcomes are needed and might overcome scepticism. 
Remote consultation could embrace the PsoWell™ approach.   
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Psoriasis is a complex, long-term inflammatory skin condition affecting 2-3% of the UK population1. 
Comorbidities are common2 and the increased risk of cardiovascular disease (CVD) for some is 
associated with obesity, physical inactivity, excess alcohol consumption and smoking3. Changing these 
health risk behaviours3 underpinning these comorbidities2 could offset increased CVD risk. 
Most clinicians recognise the role of health behaviours in managing psoriasis, but may lack the 
knowledge, skills4 or confidence to support behaviour change (BC)5. Psoriasis management has largely 
focused on physical symptoms6. The aim of BC training for professionals is to enhance communication 
skills4, increase motivation and confidence to address this wider impact of psoriasis5. The Capability, 
Motivation and Opportunity (COM-B) model identifies these three essential components in BC7. 
The fidelity of complex interventions should be rigorously tested not simply assumed8. Some 
psychological interventions appear to be effective in psoriasis9 but few have been subject to large-
scale trials. Educational and self-management training interventions typically assess patient outcomes 
only9 and few are specific to dermatology specialists. Generic studies show increased shared decision-
making and discussion and assessment of CVD risk factors, but generally do not address psychological 
illness and behaviours10. Another showed increased dermatologist satisfaction with care provision, 
discussion around well-being and recognition of health-related quality of life11. Specific training is 
required to address psychological aspects of psoriasis, support patient-centeredness and upskill 
clinicians in BC to reduce psoriasis flares and CVD risk.  
Motivational Interviewing (MI) is a collaborative consultation style used to increase internal 
motivation and capability to develop goals and action plans for BC12. This approach can bolster self-
confidence in healthcare staff and facilitate effective self-management13 of long-term conditions14 
including psoriasis9.  
MI training interventions can enhance patient understanding of psoriasis without inducing anxiety and 
facilitate a whole-person approach15. PsoWell™ (psoriasis and well-being), an MI-based training 
programme and clinical initiative that advocates a holistic, multi-disciplinary approach to managing 
people with complex psoriasis, improved primary and secondary care clinicians’ psoriasis-related 
knowledge and consultation skills16. PsoWell™ was deemed acceptable and feasible in a specialised 
setting16. Thus, MI-based interventions benefit patients and enable clinicians to provide psychological 
support.  
The PsoWell™ approach was developed in a specialist dermatology centre; the feasibility of 
incorporating MI in dermatology services with less resource is not yet established. We aimed to deliver 
an effective PsoWell™ training programme in dermatology centres across the UK and determine 
whether participants considered this training and clinical initiative feasible and acceptable to 











A cross-sectional, qualitative study involving semi-structured interviews (SSI) via telephone.  
Participants in the training programme 
Dermatology consultants, specialist nurses and registrars, as well as health and clinical psychologists 
participated in training. 
Recruitment 
Training Programme. Snowball sampling using research team contacts within dermatology, 
psychodermatology and psychology departments of the National Health Service (NHS) trusts and 
boards and academic organisations assisted with recruitment. Flyers containing study information, 
participant information sheets, and Uniform Resource Locator (URL) for the registering interest and 
training application forms (appendices A-D) were distributed to contacts. 
We aimed to recruit at least one doctor and one nurse from a centre and focused 
geographically where demand for training was highest.  
Training places were funded by the Psoriasis Association UK and were limited to 20 per group 
to enable individual skills coaching and maintain training quality.  
Evaluation. Post-training, participants were invited via email to participate in a SSI via 
telephone. There was no strict recruitment criteria, though we purposive sampling was employed to 
ensure the sample included at least two participants from each training session and represent a wide 
range of clinical roles from different dermatology services across the UK.  
Training Intervention 
Aim: A 1-day MI training programme16 aimed to improve clinicians’ knowledge and skills for 
BC and enable them to integrate MI techniques with routine dermatology consultations.  
Format: Lectures and interactive sessions plus individual coaching were delivered by 
experienced MI practitioner-trainers. See appendix E for the training agenda including the content, 
type and length of sessions.  
Materials 
Workbook. The training workbook16 contained support materials for participants. A certificate 
for individual participants and a clinic certificate for dermatology teams were awarded on completion 
of training. 
Interview schedule. Questions (appendix F) focused on the acceptability of the PsoWell™ 
model in clinical practice; the feasibility of upscaling and implementing the model in dermatology 
settings; and its usefulness in achieving a patient-centred consultation for BC.  
Procedure 





Training Programme. Sessions were organised across nine UK regions in conference and 
academic centres from October 2019 - February 2020. Participants provided written informed consent 
and populated a demographic questionnaire (appendix G) to enabled selection for the evaluation 
interview.  
Semi-structured Interviews. Encrypted audio-recorded interviews lasting 48-80 minutes were 
professionally transcribed verbatim. 
Analysis  
Semi-structured Interviews. The Information Power Model17 was used to determine the 
sample size. Data collection stopped when adequate information power was achieved: the 
comprehensive aims and cross-case analysis were balanced by the evidence, theory-based 
interventions and analysis; purposive selection from the target population; and high-quality dialogue 
generated from the interview schedule. 
Framework Analysis was conducted from an essentialist/realist epistemological standpoint describing 
the “experiences, meanings and reality of participants”18. This method facilitated a systematic and 
transparent analysis of interview data19. 
Transcripts were deductively coded against constructs of the Theoretical Framework of Acceptability 
(TFA) to determine the retrospective (experienced) and prospective (perceived) acceptability20 of the 
PsoWellTM approach. Relevant text that did not fit the TFA was coded inductively.  
Two authors independently coded one transcript before meeting with the research team to check the 
consistency of coding, resolve discrepancies, and revise the framework accordingly. This process was 
repeated until agreement was reached. The first author applied the framework (Table 1) to the 
remaining transcripts and the second author routinely sampled excerpts to ensure consistency. The 





Table 1. Theoretic Framework of Acceptability (TFA) 




"How an individual feels about the intervention."  
 
How trainees feel about the training programme or implementing the integrated clinic structure or consultation style. 
Consider positive and negative emotions. 
 
Positive Positive feelings towards the training programme or clinical approach* 
 





"The perceived amount of effort that is required to participate in the intervention."  
 
Consider the physical and mental effort required to participate in the training programme, consultation style and clinic 
structure.  
 
Physical effort Behaviours such as applying to attend; travelling to/from training; completing the training programme including specific 
training activities; or practicing/applying new skills in clinical practice. 
 





"The extent to which the intervention has a good fit with an individual's value system." Does the training 
programme/clinical approach align with the trainees’ values and morals or not? Consider whether the trainees consider 




"The extent to which the participant understands the intervention and how it works."  
 






Consider whether trainees think of Motivational Interviewing as a consultation style incorporating key principles and 
skills, including goal setting and action planning, for (lifestyle) behaviour change.   
 
Consider how trainees conceptualise the PsoWell™ approach; do they acknowledge it as integrated, multi-disciplinary and 





"The extent to which benefits, profits or values must be given up to engage in the intervention."  
 
Possible examples: taking annual leave, study days or cancelling clinics in order to attend training; loss of clinician 





"The extent to which the intervention is perceived to be likely to achieve its purpose."  
 
Consider if trainees think the training programme will improve clinicians’ knowledge, skills and confidence to address 
lifestyle within a dermatology consultation.  
 
Consider whether trainees believe the PsoWell™ approach (consultation style and clinic set-up) will improve the 





"The participant's confidence that they can perform the behaviour(s) required to participate in the intervention."   
 










Code Name Description 
 
Reason for attending training  
 









Physical and psychological factors that enable participants to engage with the training and clinic interventions. 
 
Factors that could facilitate attendance, completion or enjoyment of the training intervention. 
 









Physical and psychological factors that could negatively impact participant engagement with the training and clinic 
interventions. 
 
Factors that were perceived to deter participants from attending or completing the training intervention. 
 









Ideas for improving the PsoWell™ training or clinic intervention.  
 
Suggestions for improving the training intervention. 
 











Of the 156 people who applied, 119 (76%) completed the programme in nine locations. See Table 2 
for participant demographics. Nineteen participants (three males and 16 females) were purposively 
selected for interview comprising six dermatology consultants, five specialist nurses (two with 
academic posts), three psychologists and one each of the following: dermatology registrar, GP with 
specialist interest in dermatology, advanced care practitioner and dermatology research fellow.  
Two themes were identified: 1) Perceptions and Priorities and 2) Awareness, further divided into: 
Awareness Not Competence and Increasing Awareness. 
Perceptions and Priorities  
Clinicians reported that medical school had not prepared them to manage complex psoriasis and that 
addressing BC, especially for weight management, was challenging. All attended to improve their skills 
to ensure they were “giving the patient the best consultation” (Specialist Nurse):  
 “really seeing it as a priority, and not seeing it as an optional thing but thinking right this is 
as important as talking about side effects of medication” (Consultant Dermatologist). 
Although no formal training barriers were identified, time away from clinic was the “main restriction” 
(Dermatology Registrar) with distance to travel to the training programme another. One participant 
observed that traditional models of psoriasis management and clinical job roles do not acknowledge 
psychological and behavioural factors and thus are a potential barrier: 
“there are barriers in terms of feeling that this sort of work is for counsellors and psychologists 
as opposed to… the more usual found jobs in a dermatology department… and therefore 
struggling to make time for it erm because of a belief that it's not, it's not part of their role” 
(Clinical Psychologist). 
However, one participant felt barriers were not insurmountable: “I think if people had really wanted 
to come they'd have just got round it” (Specialist Nurse & Lecturer). Clinicians noted the benefit of the 
PsoWellTM approach and supported implementation: 
 “PsoWell and motivational interviewing is really something that should be incorporated in-
into all consultations” (Consultant Nurse). 
 “As well as job satisfaction I think that it is likely to lead to better outcomes for patients… it's 
likely to be more cost effective for the department but also, for erm, for the trust as a whole” 
(Clinical Psychologist). 
Negative perceptions of mental health provision, long waiting lists and individual motivation were 
perceived barriers to patients attending appointments. Conversely, the PsoWell™ integrated 
interdisciplinary approach to care may be acceptable to patients who report that they “want more of 
it” (Counselling Psychologist). 
Clinicians working in interdisciplinary teams highlighted the value of co-treating patients: 
 “each practitioner can bring an expertise that would be usually absent… we’ve shown in 
psycho-dermatology clinics that to have that multi-disciplinary approach is clinically 















 Country of  
training 
 Job title 
 
 Years in  
specialism 
 Size* of Dermatology 
 Service (n) 
(n)  Male Female  M (SD)  UK Other  (n)  M (SD)  Small Medium Large Other ƚ  












 Dermatology registrar  












 2.81 2.36  1 3 5 2 
North 
Yorkshire 
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 10.36 9.90  2 0 4 9 






 10.91 8.25  0 0 9 1 
                       
Total  119                     
* No predetermined criteria for determining size were employed other than whether it was located in a teaching hospital of district General Hospital. Participants were asked to self-
identify their situation for the service and the recruitment champions advised on suitability of participation.  









Furthermore, there was a clear need and desire for dedicated psychological support in dermatology: 
 “It’s something that we definitely need that we don’t know we need… both from a clinical 
team perspective, but also from a patient perspective” (Consultant Dermatologist). 
A lack of mental health services and inequities in psychology provision were identified as “broader” 
(Consultant Dermatologist) problems within the NHS. Barriers to employing psychologists included 
insufficient funding and clinic space. Some believed that MI was time consuming to implement within 
standard consultations, yet this was not always the reality in clinical practice:  
 “I thought it [MI] would end up making the consultation longer but it actually makes it 
shorter” (Consultant Dermatologist). 
Similarly, the cost of employing psychologists was raised: 
 “I’m not sure why they [doctors] think it’s expensive… they don’t compare it against, what 
actually they can save, the sort of benefit it might have in terms of use of medication… they 
don’t do all the health economics, that Psychology might involve… it’s a little bit more 
complicated, than actually saying, it’s just a salary” (Counselling Psychologist).  
Individual perceptions of job roles and time restraints may negatively affect willingness to complete 
PsoWellTM training. Implementation of this inter-disciplinary clinic approach to patient care will 
depend on service leaders’ perceptions of its value. 
Awareness 
Awareness Not Competence. The training included experiential and vicarious learning with 
feedback through role-play activities, which, despite being something that people found challenging, 
was considered fundamental for MI skills: 
“I actually got quite a lot out the role play, even though we all hate it was quite interesting to 
watch and learn from” (Advanced Care Practitioner). 
Working alongside clinicians and academics with similar “ideologies” (Consultant Dermatologist) 
provided a valuable learning opportunity to discuss experiences and “disintegrate any sense of erm 
hierarchy” (Consultant Dermatologist). Following training, clinicians felt more confident to support BC:  
“It gave me the confidence in knowing how to erm … open up those conversations on 
behavioural change, which maybe I found more difficult to do beforehand (Specialist Nurse). 
Clinicians did not claim MI expertise: “I don’t feel skilled particularly in MI” (Specialist Nurse & 
Lecturer) but seeing skills demonstrated encouraged them to be more mindful of their clinical practice: 
“it was an extremely beneficial day that erm, made me aware of different ways of conducting 
a consultation that I wouldn’t have known about before and techniques that I will put into 
clinical practice, that I think will improve the overall management of my patients” (Consultant 
Dermatologist). 
MI techniques were viewed as “the sort of things that you sort of need to practice and sort of develop 
over time” (Consultant Dermatologist). The training materials were considered a useful prompt for 
continued MI practice but practical follow-up sessions were requested to increase confidence in 





Increasing Awareness. Increased psychology provision within dermatology services was 
desirable but most recognised the need to demonstrate improved patient outcomes to convince 
budget holders to prioritise and invest in psychologists:  
“The ones who make the decisions… they have a finite pot and I think we just need to kind of 
raise, I don’t know, raise the profile or show more the benefits of, of having a psychologist in 
a service, in a way which is understood by budget holders, or service commissioners” (Specialist 
Nurse). 
Increasing awareness of the benefits of this approach at the service and policy level is necessary to 






























Participants felt better prepared to address BC with relevant patients but required further training to 
ensure competence. Outdated or inaccurate beliefs of colleagues, commissioners or service managers 
might prevent increased specialist psychological support from becoming a funding priority  
What the present study adds 
We replicated and extended the original PsoWell™ training programme findings16 in a wider sample 
of clinicians from primary, secondary, community and non-specialist settings. Participants reported 
being more knowledgeable, skilled and confident to address BC for the management of psoriasis and 
CVD risk and reported their clinical practice and research is aligned with the PsoWell™ approach. This 
was expressed most clearly among clinicians from multi-disciplinary teams including psychologists. As 
well as increasing capability, training renewed clinicians’ motivation and enthusiasm to provide 
holistic patient care through interdisciplinary working, and helped them to create opportunities during 
their routine consultations.  
‘Personal models’ (beliefs) of psoriasis influence clinicians’ approaches to patient care21. The present 
sample indicated that dermatology staff who did not believe they should address well-being or BC 
were unlikely to attend training, reinforcing the key role of beliefs about psoriasis in delivering whole-
person care.  
Implications for practice 
There is a gap in the medical curriculum relating to the wider impact of psoriasis on other conditions 
including the role of health behaviours as risk factors for those conditions. The importance of 
communication skills training for medical practitioners is now widely recognised22. The inclusion of MI 
to address psychological issues and BC across long-term conditions would be beneficial.  
PsoWell™ is an acceptable framework for the holistic management of psoriasis and potentially, other 
dermatological and long-term conditions. This study reinforces the desire in dermatology clinicians for 
dedicated psychological support provided by psychologists as well as not instead of the PsoWell™ 
approach, but this information should be communicated to service commissioners. Resourcing this 
initiative may be challenging due to the impact of Covid-19, although the subsequent shift towards 
remote service delivery presents a valuable opportunity to deliver MI in a cost-effective manner.  
Implications for future research 
We have demonstrated that brief intervention to address BC is acceptable to dermatology clinicians. 
We now need to determine if the PsoWell™ approach improves patient outcomes compared to 
standard treatment in psoriasis.  
In 2018, the top priority of the James Lind Alliance Psoriasis Priority Setting Partnership was support 
for health-related behaviour change in managing psoriasis. Testing psychological interventions for 
patients was also in the top five priorities23. Those with psoriasis and increased risk of CVD because of 
obesity and inactivity constitute a vulnerable group at greater risk of contracting Covid-1924, making 
this programme of work a priority.  
Strengths & Limitations 
We used an established BC theoretical framework to make this intervention reproducible. The 
training programme was tailored rather than generic and was delivered by experts in MI with 





Self-selection of participants may limit this work as participants were motivated by the content and 
may not represent the wider dermatology community. The first author co-delivered the training 
sessions and conducted the interviews, thereby potentially introducing bias towards participants’ 
positive training experiences. Finally, the lack of a real time evaluation of the use of MI skills is 
arguably a limitation; however, our previous work established an increase in clinicians’ consultation 
skills using this approach16. 
Conclusions 
PsoWell™ training is a necessary and acceptable BC intervention. Participants claimed it increased 
capability, confidence and motivation to support health BC in patients. They believed they could 
implement this training as part of their whole-person management practice with adequate resourcing. 
The Covid-19 pandemic has changed the way dermatology services are delivered. NHS trusts should 
capitalise on these changes to provide cost-effective MI training for staff and increase dedicated 
psychological support in face-to-face and remote dermatology consultations. 
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